Cargando…

Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop

BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) is a non‐selective cation channel that plays a pivotal role in the peripheral nervous system as a transducer of painful heat signals. Alternative splicing gives rise to several TRPM3 variants. The functional consequences of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Held, Katharina, Aloi, Vincenzo Davide, Freitas, Ana Cristina Nogueira, Janssens, Annelies, Segal, Andrei, Przibilla, Julia, Philipp, Stephan Ernst, Wang, Yu Tian, Voets, Thomas, Vriens, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290681/
https://www.ncbi.nlm.nih.gov/pubmed/32780479
http://dx.doi.org/10.1111/bph.15223
_version_ 1784748962557722624
author Held, Katharina
Aloi, Vincenzo Davide
Freitas, Ana Cristina Nogueira
Janssens, Annelies
Segal, Andrei
Przibilla, Julia
Philipp, Stephan Ernst
Wang, Yu Tian
Voets, Thomas
Vriens, Joris
author_facet Held, Katharina
Aloi, Vincenzo Davide
Freitas, Ana Cristina Nogueira
Janssens, Annelies
Segal, Andrei
Przibilla, Julia
Philipp, Stephan Ernst
Wang, Yu Tian
Voets, Thomas
Vriens, Joris
author_sort Held, Katharina
collection PubMed
description BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) is a non‐selective cation channel that plays a pivotal role in the peripheral nervous system as a transducer of painful heat signals. Alternative splicing gives rise to several TRPM3 variants. The functional consequences of these splice isoforms are poorly understood. Here, the pharmacological properties of TRPM3 variants arising from alternative splicing in the pore‐forming region were compared. EXPERIMENTAL APPROACH: Calcium microfluorimetry and patch clamp recordings were used to compare the properties of heterologously expressed TRPM3α1 (long pore variant) and TRPM3α2–α6 (short pore variants). Furthermore, site‐directed mutagenesis was done to investigate the influence of the length of the pore loop on the channel function. KEY RESULTS: All short pore loop TRPM3α variants (TRPM3α2–α6) were activated by the neurosteroid pregnenolone sulphate (PS) and by nifedipine, whereas the long pore loop variant TRPM3α1 was insensitive to either compound. In contrast, TRPM3α1 was robustly activated by clotrimazole, a compound that does not directly activate the short pore variants but potentiates their responses to PS. Clotrimazole‐activated TRPM3α1 currents were largely insensitive to established TRPM3α2 antagonists and were only partially inhibited upon activation of the μ opioid receptor. Finally, by creating a set of mutant channels with pore loops of intermediate length, we showed that the length of the pore loop dictates differential channel activation by PS and clotrimazole. CONCLUSION AND IMPLICATIONS: Alternative splicing in the pore‐forming region of TRPM3 defines the channel's pharmacological properties, which depend critically on the length of the pore‐forming loop. LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.14/issuetoc
format Online
Article
Text
id pubmed-9290681
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92906812022-07-20 Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop Held, Katharina Aloi, Vincenzo Davide Freitas, Ana Cristina Nogueira Janssens, Annelies Segal, Andrei Przibilla, Julia Philipp, Stephan Ernst Wang, Yu Tian Voets, Thomas Vriens, Joris Br J Pharmacol Article BACKGROUND AND PURPOSE: Transient receptor potential melastatin 3 (TRPM3) is a non‐selective cation channel that plays a pivotal role in the peripheral nervous system as a transducer of painful heat signals. Alternative splicing gives rise to several TRPM3 variants. The functional consequences of these splice isoforms are poorly understood. Here, the pharmacological properties of TRPM3 variants arising from alternative splicing in the pore‐forming region were compared. EXPERIMENTAL APPROACH: Calcium microfluorimetry and patch clamp recordings were used to compare the properties of heterologously expressed TRPM3α1 (long pore variant) and TRPM3α2–α6 (short pore variants). Furthermore, site‐directed mutagenesis was done to investigate the influence of the length of the pore loop on the channel function. KEY RESULTS: All short pore loop TRPM3α variants (TRPM3α2–α6) were activated by the neurosteroid pregnenolone sulphate (PS) and by nifedipine, whereas the long pore loop variant TRPM3α1 was insensitive to either compound. In contrast, TRPM3α1 was robustly activated by clotrimazole, a compound that does not directly activate the short pore variants but potentiates their responses to PS. Clotrimazole‐activated TRPM3α1 currents were largely insensitive to established TRPM3α2 antagonists and were only partially inhibited upon activation of the μ opioid receptor. Finally, by creating a set of mutant channels with pore loops of intermediate length, we showed that the length of the pore loop dictates differential channel activation by PS and clotrimazole. CONCLUSION AND IMPLICATIONS: Alternative splicing in the pore‐forming region of TRPM3 defines the channel's pharmacological properties, which depend critically on the length of the pore‐forming loop. LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.14/issuetoc John Wiley and Sons Inc. 2020-08-28 2022-07 /pmc/articles/PMC9290681/ /pubmed/32780479 http://dx.doi.org/10.1111/bph.15223 Text en © 2020 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Article
Held, Katharina
Aloi, Vincenzo Davide
Freitas, Ana Cristina Nogueira
Janssens, Annelies
Segal, Andrei
Przibilla, Julia
Philipp, Stephan Ernst
Wang, Yu Tian
Voets, Thomas
Vriens, Joris
Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
title Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
title_full Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
title_fullStr Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
title_full_unstemmed Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
title_short Pharmacological properties of TRPM3 isoforms are determined by the length of the pore loop
title_sort pharmacological properties of trpm3 isoforms are determined by the length of the pore loop
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290681/
https://www.ncbi.nlm.nih.gov/pubmed/32780479
http://dx.doi.org/10.1111/bph.15223
work_keys_str_mv AT heldkatharina pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT aloivincenzodavide pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT freitasanacristinanogueira pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT janssensannelies pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT segalandrei pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT przibillajulia pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT philippstephanernst pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT wangyutian pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT voetsthomas pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop
AT vriensjoris pharmacologicalpropertiesoftrpm3isoformsaredeterminedbythelengthoftheporeloop